TY - JOUR
T1 - Oral surgery in patients with antiphospholipid syndrome
AU - Okuyama, Kohei
AU - Naruse, Tomofumi
AU - Yutori, Hirokazu
AU - Yanamoto, Souichi
AU - Umeda, Masahiro
N1 - Publisher Copyright:
© 2019, Nihon University, School of Dentistry. All rights reserved.
PY - 2019/9
Y1 - 2019/9
N2 - Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by recurrent thrombosis, other associated autoimmune disease, and/or obstetrical morbidity along with persistent production of antiphospholipid antibodies. Because of the nature of this systemic disease, most patients are medicated with antithrombotic agents and abundant glucocorticoids. This study reports a cohort of 16 patients with APS, who underwent oral surgery between 2010 and 2017 at the Nagasaki University Hospital. Because oral antithrombotic therapy was continued in the perioperative period, all wounds were strictly closed by suturing to prevent postoperative bleeding. Perioperative laboratory dates and medications were assessed. All patients achieved local postoperative hemostasis and did not exhibit systemic complications. Moreover, there were no postoperative systemic and/or local infections. Oral surgeons should suture oral wounds and ensure local hemostasis to prevent postoperative bleeding. Because patients with APS are likely to develop thrombosis despite continued administration of antithrombotic medications, strict perioperative examination of blood coagulation is needed. Furthermore, it is important to consider the damage and stress caused due to oral surgery. Moreover, when necessary, glucocorticoid therapy should be carefully administered, in accordance with the degree of invasion and judgment of the attending physician.
AB - Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by recurrent thrombosis, other associated autoimmune disease, and/or obstetrical morbidity along with persistent production of antiphospholipid antibodies. Because of the nature of this systemic disease, most patients are medicated with antithrombotic agents and abundant glucocorticoids. This study reports a cohort of 16 patients with APS, who underwent oral surgery between 2010 and 2017 at the Nagasaki University Hospital. Because oral antithrombotic therapy was continued in the perioperative period, all wounds were strictly closed by suturing to prevent postoperative bleeding. Perioperative laboratory dates and medications were assessed. All patients achieved local postoperative hemostasis and did not exhibit systemic complications. Moreover, there were no postoperative systemic and/or local infections. Oral surgeons should suture oral wounds and ensure local hemostasis to prevent postoperative bleeding. Because patients with APS are likely to develop thrombosis despite continued administration of antithrombotic medications, strict perioperative examination of blood coagulation is needed. Furthermore, it is important to consider the damage and stress caused due to oral surgery. Moreover, when necessary, glucocorticoid therapy should be carefully administered, in accordance with the degree of invasion and judgment of the attending physician.
KW - Antiphospholipid syndrome
KW - Antithrombotic medication
KW - Collagen disease
KW - Glucocorticoid
KW - Oral surgery
KW - Postoperative local hemostasis
UR - http://www.scopus.com/inward/record.url?scp=85071715023&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071715023&partnerID=8YFLogxK
U2 - 10.2334/josnusd.18-0164
DO - 10.2334/josnusd.18-0164
M3 - Article
C2 - 31217370
AN - SCOPUS:85071715023
VL - 61
SP - 386
EP - 390
JO - Journal of oral science
JF - Journal of oral science
SN - 1343-4934
IS - 3
ER -